These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 17683845
21. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. Dezzutti CS, Hendrix CW, Marrazzo JM, Pan Z, Wang L, Louissaint N, Kalyoussef S, Torres NM, Hladik F, Parikh U, Mellors J, Hillier SL, Herold BC. PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008 [Abstract] [Full Text] [Related]
22. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. El-Sherif AM, Seth R, Tighe PJ, Jenkins D. J Pathol; 2001 Sep; 195(2):179-85. PubMed ID: 11592096 [Abstract] [Full Text] [Related]
25. [Clinical analysis of 48 patients with vaginal enlarged amputation of cervix]. Zeng SY, Li LY, Li CX, Shu KY, Pan M, Li HP, Luo B, An YT, Liang MR, Wu YY. Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):41-4. PubMed ID: 18366932 [Abstract] [Full Text] [Related]
26. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case-control study. Behbakht K, Friedman J, Heimler I, Aroutcheva A, Simoes J, Faro S. Infect Dis Obstet Gynecol; 2002 Jan; 10(4):181-6. PubMed ID: 12648311 [Abstract] [Full Text] [Related]
27. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ. Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S251-61. PubMed ID: 16188303 [Abstract] [Full Text] [Related]
28. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, Smith-McCune KK. Cancer Res; 2004 Sep 15; 64(18):6766-74. PubMed ID: 15374995 [Abstract] [Full Text] [Related]
31. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility. Mohammadi A, Bagherichimeh S, Perry MC, Fazel A, Tevlin E, Huibner S, Tharao W, Coburn B, Kaul R. Sci Rep; 2020 May 22; 10(1):8514. PubMed ID: 32444843 [Abstract] [Full Text] [Related]
32. Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis. Imseis HM, Greig PC, Livengood CH, Shunior E, Durda P, Erikson M. J Soc Gynecol Investig; 1997 May 22; 4(2):90-4. PubMed ID: 9101468 [Abstract] [Full Text] [Related]
39. Evidence of a TH1-shift of local vaginal inflammatory response during bacterial vaginosis. Anton G, Rid J, Mylonas I, Friese K, Weissenbacher ER. Infection; 2008 Mar 15; 36(2):147-52. PubMed ID: 18330506 [Abstract] [Full Text] [Related]
40. Vaginal nitric oxide in pregnant women with bacterial vaginosis. Genç MR, Delaney ML, Onderdonk AB, Witkin SS, Microbiology and Prematurity (MAP) Study Group. Am J Reprod Immunol; 2006 Aug 15; 56(2):86-90. PubMed ID: 16836610 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]